An investigation for investors in NASDAQ:CPHD shares was announced over the buyout of Cepheid by Danaher Corporation for $53 per share.
Investors who purchased shares of Cepheid (NASDAQ:CPHD) and currently hold any of those NASDAQ:CPHD shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain directors of Cepheid breached their fiduciary duties owed to NASDAQ:CPHD investors in connection with the proposed acquisition.
On September 6, 2016, Cepheid announced that it has entered into an agreement with Danaher Corporation (NYSE: DHR) under which Danaher will acquire all of the outstanding shares of Cepheid (NASDAQ:CPHD) common stock for $53 per share in cash, or a total enterprise value of approximately $4 billion including indebtedness and net of acquired cash.
However, the investigation concerns whether the offer is unfair to Cepheid (NASDAQ:CPHD stockholders. More specifically, the investigation concerns whether the Cepheid (NASDAQ:CPHD Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
On September 21, 2016, NASDAQ:CPHD shares closed at $52.53 per share.
Those who are current investors in NASDAQ:CPHD shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com